The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375

Phase 1 Unknown 28 enrolled Chong Kun Dang Pharmaceutical

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this clinical trial is to evaluate the pharmacokinetics and safety/tolerability after oral administration of CKD-375 and D387 in healthy adults.

Timeline

Start: 2019-04-14
Primary completion: 2019-04-24
Completion: 2019-05-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CKD-375	Unknown	—	Oral
Subject	D387	Unknown	—	Oral

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375

Summary

Timeline

Drugs

Indications